| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $30.15B | -25.2% |
| Cost of Revenue | $27.58B | -22.8% |
| R&D Expense | $136.0M | +0.7% |
| SG&A Expense | $1.61B | -3.2% |
| Operating Income | -$420.0M | -123.1% |
| Pre-tax Income | -$715.0M | -144.6% |
| Income Tax | $70.0M | -70.8% |
| Net Income | -$738.0M | -154.0% |
| EPS (Basic) | -$2.34 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.44B | +2.0% |
| Short-term Investments | $2.03B | -22.2% |
| Inventory | $3.53B | -24.2% |
| Current Assets | $10.87B | -11.4% |
| Total Assets | $34.00B | -4.9% |
| Current Liabilities | $6.13B | -8.6% |
| Long-term Debt | $12.12B | +15.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.26B | -40.8% |
| Capital Expenditures | $1.88B | +2.1% |
| Investing Cash Flow | -$1.78B | +4.2% |
| Financing Cash Flow | -$507.0M | +73.2% |
| Free Cash Flow | $384.0M | -80.6% |
| -156.3% |
| EPS (Diluted) | -$2.34 | -156.4% |
| Stockholders' Equity |
| $10.08B |
| -19.1% |